Stada Boards Back Sweetened €4.12B Bain, Cinven Buyout

German pharmaceutical company Stada Arzneimittel AG on Tuesday encouraged shareholders to accept a sweetened €4.12 billion ($4.8 billion) takeover offer from Bain Capital and Cinven, after an earlier buyout offer from...

Already a subscriber? Click here to view full article